Note: Ingredients listed on restricted chemical lists
EC/CAS
200-484-5/60-57-1
Name of the chemical
Dieldrin (ISO)
Concentration
<= 100 %
General Information
Version
6.3
Revision date
2021-09-10
Product name
Dieldrin
CAS No.
60-57-1
REACH No
A
Emergency telephone
800-424-9300, +1-703- 527-3887
Icons in SDS
Company Information
company name
Sigma-Aldrich Inc
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H300+H310, H351, H372, H410
Hazard statements
Code
Statements
H300+H310
Fatal if swallowed or in contact with skin
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008] Classification of the substance or mixture
Signal word
Danger
Hazard statements
H300 + H310 Fatal if swallowed or in contact with skin. H351 Suspected of causing cancer. H372 Causes damage to organs through prolonged or repeated exposure. H410 Very toxic to aquatic life with long lasting effects.
Precautionary statements
P260 Do not breathe dust/ fume/ gas/ mist/ vapors/ spray. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P301 + P330 + P331 + IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. P310 Immediately call a POISON CENTER/ doctor. P302 + P352 + P310 IF ON SKIN: Wash with plenty of water. Immediately call a POISON CENTER/ doctor. P361 + P364 Take off immediately all contaminated clothing and wash it before reuse.
Supplemental label elements
none
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 Acute toxicity, Oral (Category 2), H300 Acute toxicity, Dermal (Category 1), H310 Carcinogenicity (Category 2), H351 Specific target organ toxicity - repeated exposure (Category 1), H372 Short-term (acute) aquatic hazard (Category 1), H400 Long-term (chronic) aquatic hazard (Category 1), H410 For the full text of the H-Statements mentioned in this Section, see Section 16.